PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis

American Journal of Pathology

Volumn 180, Issue 5, 2012, Pages 1906-1916

  Bartok, Beatrix ^a   Boyle, David L ^a   Liu, Yi ^c   Ren, Pingda ^c   Ball, Scott T ^b   Bugbee, William D ^d   Rommel, Christian ^c   Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Intellikines Inc ^*  (United States)

^c Intellikine Inc   (United States)

^d SCRIPPS HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; INK 007; INTERLEUKIN 1; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE DELTA; PHOSPHATIDYLINOSITOL 3 KINASE DELTA BETA; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; WESTERN BLOTTING;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; ENZYME INHIBITORS; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION MEDIATORS; OSTEOARTHRITIS; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SYNOVIAL MEMBRANE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84860114297     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.01.030     Document Type: Article

References (65)

1. S.J. Harris, J.G. Foster, S.G. Ward PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies Curr Opin Investig Drugs 10 2009 1151 1162
2. C. Rommel, M. Camps, H. Ji PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol 7 2007 191 201
3. O. Williams, B.T. Houseman, E.J. Kunkel, B. Aizenstein, R. Hoffman, Z.A. Knight, K.M. Shokat Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs Chem Biol 17 2010 123 134
4. B. Vanhaesebroeck, S.J. Leevers, K. Ahmadi, J. Timms, R. Katso, P.C. Driscoll, R. Woscholski, P.J. Parker, M.D. Waterfield Synthesis and function of 3-phosphorylated inositol lipids Annu Rev Biochem 70 2001 535 602
5. B. Vanhaesebroeck, M.J. Welham, K. Kotani, R. Stein, P.H. Warne, M.J. Zvelebil, K. Higashi, S. Volinia, J. Downward, M.D. Waterfield P110delta, a novel phosphoinositide 3-kinase in leukocytes Proc Natl Acad Sci USA 94 1997 4330 4335
6. K.D. Puri, T.A. Doggett, J. Douangpanya, Y. Hou, W.T. Tino, T. Wilson, T. Graf, E. Clayton, M. Turner, J.S. Hayflick, T.G. Diacovo Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue Blood 103 2004 3448 3456
7. K.D. Puri, T.A. Doggett, C.Y. Huang, J. Douangpanya, J.S. Hayflick, M. Turner, J. Penninger, T.G. Diacovo The role of endothelial PI3Kgamma activity in neutrophil trafficking Blood 106 2005 150 157
8. K. Okkenhaug, A. Bilancio, G. Farjot, H. Priddle, S. Sancho, E. Peskett, W. Pearce, S.E. Meek, A. Salpekar, M.D. Waterfield, A.J. Smith, B. Vanhaesebroeck Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice Science 297 2002 1031 1034
9. E. Clayton, G. Bardi, S.E. Bell, D. Chantry, C.P. Downes, A. Gray, L.A. Humphries, D. Rawlings, H. Reynolds, E. Vigorito, M. Turner A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation J Exp Med 196 2002 753 763
10. F. Ramadani, D.J. Bolland, F. Garcon, J.L. Emery, B. Vanhaesebroeck, A.E. Corcoran, K. Okkenhaug The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development Sci Signal 3 2010 ra60
11. D.T. Patton, O.A. Garden, W.P. Pearce, L.E. Clough, C.R. Monk, E. Leung, W.C. Rowan, S. Sancho, L.S. Walker, B. Vanhaesebroeck, K. Okkenhaug Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells J Immunol 177 2006 6598 6602
12. S.T. Jou, N. Carpino, Y. Takahashi, R. Piekorz, J.R. Chao, D. Wang, J.N. Ihle Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex Mol Cell Biol 22 2002 8580 8591
13. E. Hirsch, V.L. Katanaev, C. Garlanda, O. Azzolino, L. Pirola, L. Silengo, S. Sozzani, A. Mantovani, F. Altruda, M.P. Wymann Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation Science 287 2000 1049 1053
14. Z. Li, H. Jiang, W. Xie, Z. Zhang, A.V. Smrcka, D. Wu Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction Science 287 2000 1046 1049
15. G.E. Jones, E. Prigmore, R. Calvez, C. Hogan, G.A. Dunn, E. Hirsch, M.P. Wymann, A.J. Ridley Requirement for PI 3-kinase gamma in macrophage migration to MCP-1 and CSF-1 Exp Cell Res 290 2003 120 131
16. C. Ferrandi, V. Ardissone, P. Ferro, T. Ruckle, P. Zaratin, E. Ammannati, E. Hauben, C. Rommel, R. Cirillo Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment J Pharmacol Exp Ther 322 2007 923 930
17. W.P. Fung-Leung Phosphoinositide 3-kinase delta (PI3Kdelta) in leukocyte signaling and function Cell Signal 23 2011 603 608
18. B. Bartok, G.S. Firestein Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis Immunol Rev 233 2010 233 255
19. J.M. Alvaro-Gracia, N.J. Zvaifler, C.B. Brown, K. Kaushansky, G.S. Firestein Cytokines in chronic inflammatory arthritis VI Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha J Immunol 146 1991 3365 3371
20. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315 324
21. M. Sun, P. Hillmann, B.T. Hofmann, J.R. Hart, P.K. Vogt Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha Proc Natl Acad Sci USA 107 2010 15547 15552
22. A.M. Condliffe, K. Davidson, K.E. Anderson, C.D. Ellson, T. Crabbe, K. Okkenhaug, B. Vanhaesebroeck, M. Turner, L. Webb, M.P. Wymann, E. Hirsch, T. Ruckle, M. Camps, C. Rommel, S.P. Jackson, E.R. Chilvers, L.R. Stephens, P.T. Hawkins Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils Blood 106 2005 1432 1440
23. S. Hayer, N. Pundt, M.A. Peters, C. Wunrau, I. Kuhnel, K. Neugebauer, S. Strietholt, J. Zwerina, A. Korb, J. Penninger, L.A. Joosten, S. Gay, T. Ruckle, G. Schett, T. Pap PI3Kgamma regulates cartilage damage in chronic inflammatory arthritis FASEB J 23 2009 4288 4298
24. S.E. Herman, A.L. Gordon, A.J. Wagner, N.A. Heerema, W. Zhao, J.M. Flynn, J. Jones, L. Andritsos, K.D. Puri, B.J. Lannutti, N.A. Giese, X. Zhang, L. Wei, J.C. Byrd, A.J. Johnson Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals Blood 116 2010 2078 2088
25. J. Hoellenriegel, S.A. Meadows, M. Sivina, W.G. Wierda, H. Kantarjian, M.J. Keating, N. Giese, S. O'Brien, A. Yu, L.L. Miller, B.J. Lannutti, J.A. Burger The phosphoinositide 3′-kinase delta inhibitor CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia Blood 118 2011 3603 3612
26. B.J. Lannutti, S.A. Meadows, S.E. Herman, A. Kashishian, B. Steiner, A.J. Johnson, J.C. Byrd, J.W. Tyner, M.M. Loriaux, M. Deininger, B.J. Druker, K.D. Puri, R.G. Ulrich, N.A. Giese CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability Blood 117 2011 591 594
27. M.J. Elices, V. Tsai, D. Strahl, A.S. Goel, V. Tollefson, T. Arrhenius, E.A. Wayner, F.C. Gaeta, J.D. Fikes, G.S. Firestein Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature J Clin Invest 93 1994 405 416
28. M. Chabaud-Riou, G.S. Firestein Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis Am J Pathol 164 2004 177 184
29. D.L. Boyle, S. Rosengren, W. Bugbee, A. Kavanaugh, G.S. Firestein Quantitative biomarker analysis of synovial gene expression by real-time PCR Arthritis Res Ther 5 2003 R352 R360
30. D.A. Fruman, G. Bismuth Fine tuning the immune response with PI3K Immunol Rev 228 2009 253 272
31. K.R. Aupperle, D.L. Boyle, M. Hendrix, E.A. Seftor, N.J. Zvaifler, M. Barbosa, G.S. Firestein Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene Am J Pathol 152 1998 1091 1098
32. L. Moreland Unmet needs in rheumatoid arthritis Arthritis Res Ther 3 7 Suppl 2005 S2 S8
33. S. Cohen, R. Fleischmann Kinase inhibitors: a new approach to rheumatoid arthritis treatment Curr Opin Rheumatol 22 2010 330 335
34. S.E. Sweeney, G.S. Firestein Primer: signal transduction in rheumatic disease-a clinician's guide Nat Clin Pract Rheumatol 3 2007 651 660
35. A. Ghigo, F. Damilano, L. Braccini, E. Hirsch PI3K inhibition in inflammation: toward tailored therapies for specific diseases Bioessays 32 2010 185 196
36. L. Bi, I. Okabe, D.J. Bernard, A. Wynshaw-Boris, R.L. Nussbaum Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase J Biol Chem 274 1999 10963 10968
37. L. Bi, I. Okabe, D.J. Bernard, R.L. Nussbaum Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase Mamm Genome 13 2002 169 172
38. A. Bilancio, K. Okkenhaug, M. Camps, J.L. Emery, T. Ruckle, C. Rommel, B. Vanhaesebroeck Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells Blood 107 2006 642 650
39. K. Kok, B. Geering, B. Vanhaesebroeck Regulation of phosphoinositide 3-kinase expression in health and disease Trends Biochem Sci 34 2009 115 127
40. B. Vanhaesebroeck, K. Ali, A. Bilancio, B. Geering, L.C. Foukas Signalling by PI3K isoforms: insights from gene-targeted mice Trends Biochem Sci 30 2005 194 204
41. L. Liu, K.D. Puri, J.M. Penninger, P. Kubes Leukocyte PI3Kgamma and PI3Kdelta have temporally distinct roles for leukocyte recruitment in vivo Blood 110 2007 1191 1198
42. K. Okkenhaug, B. Vanhaesebroeck New responsibilities for the PI3K regulatory subunit p85 alpha Sci STKE 2001 2001 pe1
43. S.M. Brachmann, K. Ueki, J.A. Engelman, R.C. Kahn, L.C. Cantley Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice Mol Cell Biol 25 2005 1596 1607
44. E. Patrucco, A. Notte, L. Barberis, G. Selvetella, A. Maffei, M. Brancaccio, S. Marengo, G. Russo, O. Azzolino, S.D. Rybalkin, L. Silengo, F. Altruda, R. Wetzker, M.P. Wymann, G. Lembo, E. Hirsch PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects Cell 118 2004 375 387
45. T. Inoue, D. Hammaker, D.L. Boyle, G.S. Firestein Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes J Immunol 174 2005 4301 4306
46. B. Vanhaesebroeck, P.K. Vogt, C. Rommel PI3K: From the Bench to the Clinic and Back Curr Top Microbiol Immunol 2010
47. K.S. Lee, H.K. Lee, J.S. Hayflick, Y.C. Lee, K.D. Puri Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model FASEB J 20 2006 455 465
48. J.A. Marwick, G. Caramori, P. Casolari, F. Mazzoni, P.A. Kirkham, I.M. Adcock, K.F. Chung, A. Papi A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease J Allergy Clin Immunol 125 2010 1146 1153
49. B.F. Nashed, T. Zhang, M. Al-Alwan, G. Srinivasan, A.J. Halayko, K. Okkenhaug, B. Vanhaesebroeck, K.T. Hayglass, A.J. Marshall Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation Eur J Immunol 37 2007 416 424
50. S.J. Park, K.S. Lee, S.R. Kim, K.H. Min, H. Moon, M.H. Lee, C.R. Chung, H.J. Han, K.D. Puri, Y.C. Lee Phosphoinositide 3-kinase delta inhibitor suppresses interleukin-17 expression in a murine asthma model Eur Respir J 36 2010 1448 1459
51. T.M. Randis, K.D. Puri, H. Zhou, T.G. Diacovo Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils Eur J Immunol 38 2008 1215 1224
52. H.G. Zhang, Y. Wang, J.F. Xie, X. Liang, D. Liu, P. Yang, H.C. Hsu, R.B. Ray, J.D. Mountz Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt Arthritis Rheum 44 2001 1555 1567
53. Q. Pu, D. Zhuang, S. Thakran, A. Hassid Mechanisms related to NO-induced motility in differentiated rat aortic smooth muscle cells Am J Physiol Heart Circ Physiol 300 2011 H101 H108
54. D. Boller, A. Schramm, K.T. Doepfner, T. Shalaby, A.O. von Bueren, A. Eggert, M.A. Grotzer, A. Arcaro Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells Clin Cancer Res 14 2008 1172 1181
55. C. Sawyer, J. Sturge, D.C. Bennett, M.J. O'Hare, W.E. Allen, J. Bain, G.E. Jones, B. Vanhaesebroeck Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta Cancer Res 63 2003 1667 1675
56. L.M. Moir, T. Trian, Q. Ge, P.R. Shepherd, J.K. Burgess, B.G. Oliver, J.L. Black PI 3-Kinase isoform specific effects in airway mesenchymal cell function J Pharmacol Exp Ther 2011
57. F. Kullmann, M. Judex, I. Neudecker, S. Lechner, H.P. Justen, D.R. Green, D. Wessinghage, G.S. Firestein, S. Gay, J. Scholmerich, U. Muller-Ladner Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts Arthritis Rheum 42 1999 1594 1600
58. B.J. Eickholt, A.I. Ahmed, M. Davies, E.A. Papakonstanti, W. Pearce, M.L. Starkey, A. Bilancio, A.C. Need, A.J. Smith, S.M. Hall, F.P. Hamers, K.P. Giese, E.J. Bradbury, B. Vanhaesebroeck Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase PLoS One 2 2007 e869
59. J. Wang, Z.A. Knight, D. Fiedler, O. Williams, K.M. Shokat, D. Pearce Activity of the p110-alpha subunit of phosphatidylinositol-3-kinase is required for activation of epithelial sodium transport Am J Physiol Renal Physiol 295 2008 F843 F850
60. J. Morel, R. Audo, M. Hahne, B. Combe Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt J Biol Chem 280 2005 15709 15718
61. S. Garcia, M. Liz, J.J. Gomez-Reino, C. Conde Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage Arthritis Res Ther 12 2010 R33
62. R. Audo, B. Combe, B. Coulet, J. Morel, M. Hahne The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases Cell Death Differ 16 2009 1227 1237
63. E.A. Papakonstanti, A.J. Ridley, B. Vanhaesebroeck The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN EMBO J 26 2007 3050 3061
64. C. Billottet, V.L. Grandage, R.E. Gale, A. Quattropani, C. Rommel, B. Vanhaesebroeck, A. Khwaja A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16 Oncogene 25 2006 6648 6659
65. M.A. Whitehead, M. Bombardieri, C. Pitzalis, Vanhaesebroeck Isoform selective induction of human p100d PI3K expression by TNFa: identification of a new and inducible PI3KCD promoter Biochem J 2012 10.1042/BJ20112214